MCQOPTIONS
Saved Bookmarks
| 1. |
In October 2020, which of the following has received the Securities and Exchange Board of India’s approval to go ahead with its proposed ₹6,000 crore IPO? |
| A. | Gland Pharma Ltd |
| B. | Aurobindo Pharma |
| C. | Sms Pharmaceuticals |
| D. | Intas Biopharmaceuticals |
| E. | Mankind Pharma |
| Answer» B. Aurobindo Pharma | |